["{\n\"step_by_step_thinking\": \"The increased standard error in the pulmharkimab 150 mg/day group is likely due to a smaller sample size. The table shows that there were 202 participants in this group compared to 388 and 395 participants in the other two groups, respectively.\",\n\"answer_choice\": \"C\""]